Interestingly, DBPDE+BRB treated mice with papillomas and invasive cancer have increased p120ctn expression in papillomas and invasive cancer (Fig 5C and 5D, respectively) relative to DBPDE-only treated mice. The gene discussed is CTNND1; the disease is papilloma.